N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-((2-oxo-1,2,5,6,7,8-hexahydroquinazolin-4-yl)thio)acetamide结构式
|
常用名 | N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-((2-oxo-1,2,5,6,7,8-hexahydroquinazolin-4-yl)thio)acetamide | 英文名 | N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-((2-oxo-1,2,5,6,7,8-hexahydroquinazolin-4-yl)thio)acetamide |
|---|---|---|---|---|
| CAS号 | 933203-84-0 | 分子量 | 351.5 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C14H17N5O2S2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-((2-oxo-1,2,5,6,7,8-hexahydroquinazolin-4-yl)thio)acetamide |
|---|
| 分子式 | C14H17N5O2S2 |
|---|---|
| 分子量 | 351.5 |
| InChIKey | HXQYQWCMIKIRLI-UHFFFAOYSA-N |
| SMILES | CCC1=NN=C(S1)NC(=O)CSC2=NC(=O)NC3=C2CCCC3 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|